How The Insulet (PODD) Narrative Is Shifting With Omnipod 5 And Rising Competition

Insulet’s modeled fair value per share has been tweaked from US$354.40 to US$354.12, a very small adjustment that still caught investors’ attention. That subtle move lines up with a research backdrop ...
Everyday Health

Some Omnipod Insulin Pods Recalled for Dangerous Leakage

A tear in the tubing may prevent users from getting full insulin doses. So far 18 people have reported serious issues related ...

Why Insulet (PODD) Is Down 7.2% After Omnipod 5 Recall Over Insulin Under-Delivery Risk

Earlier this week, Insulet announced a voluntary medical device correction and recall for specific Omnipod 5 pod lots in the US after detecting a manufacturing defect that can cause insulin ...
FOX 10 Phoenix

Insulin devices recalled over leak risk, reports of 'serious adverse events'

An insulin pump maker is recalling certain pods that can fail to fully infuse insulin in the body. The recall comes after 18 reports of “serious adverse events." ...
Medical Device Network on MSN

Insulet initiates Omnipod 5 recall following 18 AE reports

Insulet estimates that the pods involved in this correction represent approximately 1.5% of annual production globally.

Insulet recalling certain defective Omnipod insulin delivery devices

Insulet Corporation (PODD) has initiated a voluntary recall of certain lots of its Omnipod 5 insulin delivery Pods in the U.S. after detecting that some devices had a manufacturing defect that causes ...

Diabetic insulin pods recalled for manufacturing issue

( NewsNation) — Type-1 Diabetes insulin pods have been recalled over a manufacturing issue, according to the U.S. Food and ...

Insulet Initiates Voluntary Correction For Omnipod 5, Expects $40M of Related Costs

Insulet expects to incur up to $40 million in costs associated with the correction in 2026 and does not anticipate updating its previously issued guidance for the year, according to a filing with the ...

Insulet stock hits 52-week low - here's why

Insulet Corp. PODD shares are down during Friday’s premarket session following the company’s announcement of a voluntary Medical Device Correction for certain lots of Omnipod 5 Pods. Manufacturing ...
Fierce Biotech

Insulet recalls certain Omnipod 5 pumps over insulin leak risks

Insulet has begun recalling specific lots of its Omnipod 5 insulin pumps in the U.S. | The diabetes tech company said it is aware of 18 cases of serious complications related to the under-delivery of ...
Seeking Alpha

Insulet Launches Omnipod® 5 Automated Insulin Delivery System in Canada, a Revolutionary New Technology for People Living with Type 1 Diabetes Ages Two Years and Above

OAKVILLE, ON, April 7, 2025 /CNW/ - Insulet Corporation (PODD), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced that Omnipod 5 is now ...
Morningstar

Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future

Expansion follows successful multi-year pilots in Massachusetts and California, and longstanding Pod takeback programs in Europe, Canada, and Australia Insulet Corporation (NASDAQ: PODD) (“Insulet” or ...